SCHEMBL29814926

CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)CNC(=O)CNC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)CC(N)=O)[C@@H](C)O)[C@@H](C)O)[C@@H](C)O)C(=O)O

nearest known ligand 0.59

Predicted protein targets (top 12)

	gene	UniProt	supporting neighbours	confidence
▸	TFPI	P10646	1/20	0.50

▸	RAMP3	O60896	6/20	0.47

▸	CALCR	P30988	6/20	0.47

▸	VIPR1	P32241	2/20	0.46

▸	OPRM1	P35372	1/20	0.46

▸	OPRD1	P41143	1/20	0.46

▸	OPRK1	P41145	1/20	0.46

▸	ECE1	P42892	1/20	0.46

▸	GLP1R	P43220	1/20	0.46

▸	MUS81	Q96NY9	1/20	0.46

▸	VIPR2	P41587	1/20	0.45

▸	OPRL1	P41146	1/20	0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL30435760	0.88	TFPI (0.52)	TFPIVIPR1ECE1GLP1RMUS81
SCHEMBL29689157	0.88	NPY4R (0.47)	OPRM1OPRD1OPRK1
SCHEMBL30432032	0.88	OPRL1 (0.48)	TFPIRAMP3CALCRVIPR1ECE1
SCHEMBL30786594	0.87	NPY4R (0.47)	VIPR1VIPR2
SCHEMBL29940169	0.87	TFPI (0.51)	TFPIRAMP3CALCRVIPR1OPRM1
SCHEMBL30262036	0.87	VIPR1 (0.52)	TFPIVIPR1VIPR2
SCHEMBL30974563	0.86	TFPI (0.51)	TFPI
SCHEMBL30571160	0.86	TFPI (0.51)	TFPIRAMP3CALCRVIPR1OPRM1
SCHEMBL30880884	0.86	VIPR1 (0.46)	VIPR1ECE1GLP1RMUS81VIPR2
SCHEMBL30520096	0.85	RAMP3 (0.47)	TFPIRAMP3CALCRECE1GLP1R

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20220242964-A1	COMPOSITIONS AND METHODS FOR REGULATING ERYTHROPOIESIS	UNIVERSITY OF VIRGINIA PATENT FOUNDATION	2022-08-04	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20220242964-A1	COMPOSITIONS AND METHODS FOR REGULATING ERYTHROPOIESIS	EPOR, CD47, CD44	TFPI 4613/4885RAMP3 2326/4885CALCR 1693/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.